HIGHLIGHTS
- who: Mesoporous Polydopamine Loaded et al. from the Department of Nuclear Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China, State Key have published the Article: Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy, in the Journal: (JOURNAL)
SUMMARY
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org July 2022 | Volume 10 | Article 920766 Targeted Nanodrug for Pulmonary Fibrosis interests many researchers (Wenlong et_al, 2015; Lin et_al, 2019; Wu et_al, 2020; Bergmann et_al, 2021; Rohrich et_al, 2022). Nanodrugs that utilize nanoparticles as drug delivery carriers for targeting . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.